NextCure, Inc. (NXTC) earnings

NXTC earnings moved a median of -0.81% by the close. Quarterly and annual NXTC reports and results, each read against the price at its own news timestamp. Back to the NXTC overview →

21 measured NXTC earnings events.

Where these NXTC earnings landedvs 21 measured NXTC earnings reactions
NXTC earningsMiddle 50% · -4.38% to +4.58%Zero: 0.00%Median: -0.81%Median -0.81%-6.00%0+6.00%
Middle 50% of NXTC earnings reactions-4.38% to +4.58%
Median reaction (to close)-0.81%
Measured reactions21
Point-in-time · zero look-ahead

Half of the 21 NXTC earnings events with a measured close landed between -4.38% and +4.58%; 48% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q NextCure, Inc. For: Jun 30SEC filing · Form 10-Q-1.14%+10.82%
NextCure Provides Business Update and Reports Second Quarter 2026 Financial ResultsPress release-1.14%+10.82%
Form 10-Q NextCure, Inc. For: Mar 31SEC filing · Form 10-Q+0.00%-4.13%
NextCure Provides Business Update and Reports First Quarter 2026 Financial ResultsPress release+0.00%-4.13%
Form 10-K NextCure, Inc. For: Dec 31SEC filing · Form 10-K+0.00%-2.75%
Form 10-Q NextCure, Inc. For: Sep 30SEC filing · Form 10-Q-0.52%+2.61%
NextCure Provides Business Update and Reports Third Quarter 2025 Financial ResultsPress release-0.52%+2.61%
Form 10-Q NextCure, Inc. For: Jun 30SEC filing · Form 10-Q+3.77%-0.81%
NextCure Provides Business Update and Reports Second Quarter 2025 Financial ResultsPress release+3.77%-0.81%
Form 10-Q NextCure, Inc. For: Mar 31SEC filing · Form 10-Q+2.04%-5.85%
NextCure Provides Business Update and Reports First Quarter 2025 Financial ResultsPress release+2.04%-5.85%
Form 10-K NextCure, Inc. For: Dec 31SEC filing · Form 10-K—+10.24%
Form 10-Q NextCure, Inc. For: Sep 30SEC filing · Form 10-Q—-4.44%
NextCure Provides Business Update and Reports Third Quarter 2024 Financial ResultsPress release—-4.44%
Form 10-Q NextCure, Inc. For: Jun 30SEC filing · Form 10-Q-1.63%+4.58%
NextCure Provides Business Update and Reports Second Quarter 2024 Financial ResultsPress release-1.63%+4.58%
Form 10-Q NextCure, Inc. For: Mar 31SEC filing · Form 10-Q-0.63%-4.38%
NextCure Provides Business Update and Reports First Quarter 2024 Financial ResultsPress release-0.63%-4.38%
Form 10-K NextCure, Inc. For: Dec 31SEC filing · Form 10-K+2.80%+17.48%
Form 10-Q NextCure, Inc. For: Sep 30SEC filing · Form 10-Q+0.85%+1.72%
NextCure Provides Business Update and Reports Third Quarter 2023 Financial ResultsPress release+0.85%+1.72%
That’s how NXTC usually reacts to earnings — get an email when it moves on news →
Keep exploring

More NXTC: analyst actions → · SEC filings → · NXTC overview →